Human Class I structures
951 items
Page 21 of 39 | 25 items per page | ordered by release date, descending
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39| 3X14 |
HLA-B*08:01 binding "FLRGRAYGL" at 2.00Å resolution |
| 4U6X |
HLA-A*02:01 binding "ALQDAGDSSRKEYFI" at 1.68Å resolution |
| 3X11 |
HLA-B*57:01 binding "LSSPVTKSF" at 2.15Å resolution |
| 4NO3 |
HLA-A*02:01 binding "RQISQDVKL" at 1.70Å resolution |
| 4NO5 |
HLA-A*02:01 binding "RQISQDVKL" at 2.10Å resolution |
| 3X13 |
HLA-B*08:01 binding "FLRGRAYGL" at 1.80Å resolution |
| 4QOK |
HLA-A*02:01 presenting "EAAGIGILTV" to Alpha/Beta T cell receptor at 3.00Å resolution |
| 4QRS |
HLA-B*08:01 binding "ELKRKMIYM" at 1.40Å resolution |
| 4QRR |
HLA-B*35:01 presenting "IPSINVHHY" to Alpha/Beta T cell receptor at 3.00Å resolution |
| 4NO2 |
HLA-A*02:01 binding "RQASIELPSMAV" at 2.00Å resolution |
| 4NNY |
HLA-A*02:01 binding "RQASLSISV" at 1.90Å resolution |
| 4NNX |
HLA-A*02:01 binding "RQASLSISV" at 2.10Å resolution |
| 4NO0 |
HLA-A*02:01 binding "RQASIELPSMAV" with LIR-1 NK receptor at 2.70Å resolution |
| 4QRQ |
HLA-B*08:01 binding "HSKKKCDEL" at 1.70Å resolution |
| 4QRP |
HLA-B*08:01 presenting "HSKKKCDEL" to Alpha/Beta T cell receptor at 2.90Å resolution |
| 4WJ5 |
HLA-A*02:01 binding "XVAGIGILTX" at 1.65Å resolution |
| 4MJ6 |
HLA-A*11:01 binding "TMVMELIRMIK" at 2.57Å resolution |
| 4MJ5 |
HLA-A*11:01 binding "TIAMELIRMIK" at 2.40Å resolution |
| 4UQ2 |
HLA-A*11:01 binding "AIMXYPK" at 2.43Å resolution |
| 4UQ3 |
HLA-A*02:01 binding "GLSXXL" at 2.10Å resolution |
| 4O2E |
HLA-B*39:01 binding "SHVAVENAL" at 1.98Å resolution |
| 4O2F |
HLA-B*39:01 binding "HVAVENAL" at 1.90Å resolution |
| 4LNR |
HLA-B*35:01 binding "RPQVPLRPMTY" at 2.00Å resolution |
| 4O2C |
HLA-B*39:01 binding "XSHVAVENAL" at 1.80Å resolution |
| 4NT6 |
HLA-C*08:01 binding "GILGFVFTL" at 1.84Å resolution |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39

This work is licensed under a Creative Commons Attribution 4.0 International License.